Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06669572
What this trial is testing

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Who this might be right for
Carcinoma, Squamous CellAnorectal Cancer
University of Chicago 35
Testing effectiveness (Phase 2)UnknownNCT02388581
What this trial is testing

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

Who this might be right for
Gastric Diffuse Large B-cell Lymphoma
National Health Research Institutes, Taiwan 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07271602
What this trial is testing

Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung CancerImmunotherapyRadiotherapy+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Testing effectiveness (Phase 2)Study completedNCT00063401
What this trial is testing

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
Eli Lilly and Company 39
Early research (Phase 1)UnknownNCT03823365
What this trial is testing

Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
A.O. Ospedale Papa Giovanni XXIII 19
Testing effectiveness (Phase 2)Ended earlyNCT02488694
What this trial is testing

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer With Somatic EGFR Mutations
AIO-Studien-gGmbH 4
Post-approval studies (Phase 4)Study completedNCT02581995
What this trial is testing

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

Who this might be right for
Macular Edema
Bayer 560
Large-scale testing (Phase 3)Study completedNCT00901901
What this trial is testing

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 732
Testing effectiveness (Phase 2)Study completedNCT00514475
What this trial is testing

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Oslo University Hospital 160
Not applicableUnknownNCT05729737
What this trial is testing

Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

Who this might be right for
Pancreatic CancerUltrasonographyFirst-line Chemotherapy
Peking Union Medical College Hospital 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05502237
What this trial is testing

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Gilead Sciences 1,021
Testing effectiveness (Phase 2)Study completedNCT00147537
What this trial is testing

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 282
Not applicableNot Yet RecruitingNCT05222945
What this trial is testing

Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 34
Early research (Phase 1)Looking for participantsNCT07392372
What this trial is testing

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 67
Large-scale testing (Phase 3)Looking for participantsNCT07100730
What this trial is testing

Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Neoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 50
Large-scale testing (Phase 3)Looking for participantsNCT07702032
What this trial is testing

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

Who this might be right for
Left-sided Colorectal Cancer
Genmab 960
Not applicableNot Yet RecruitingNCT07064772
What this trial is testing

The Immediate Effects of First Rib Mobilization on Pain and Range of Motion in Patients With Shoulder Pain

Who this might be right for
Shoulder Pain
Andrews University 64
Large-scale testing (Phase 3)Looking for participantsNCT07228832
What this trial is testing

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Summit Therapeutics 600
Post-approval studies (Phase 4)Ended earlyNCT00975663
What this trial is testing

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

Who this might be right for
Lung and Heart-lung Transplantation
University Hospital, Limoges 180
Not applicableUnknownNCT01813344
What this trial is testing

Hyper-CVAD Treatment in Lymphoblastic Lymphoma

Who this might be right for
Lymphoblastic Lymphoma
Ajou University School of Medicine 50
Next Page